Concentrix Corporation — Form 8-K Summary
Report date: April 21, 2023; filed April 26, 2023. The filing reports financing arrangements related to Concentrix’s proposed combination with Webhelp. It does not provide quarterly or annual operating results for a reporting period.
Business Context and Transaction
Concentrix entered into an Amendment and Restatement Agreement that amended and restated its October 16, 2020 credit agreement. The financing supports the proposed acquisition of Webhelp Parent, subject to customary closing conditions. The combination was expected to close before the end of 2023, but completion was not assured.
Financing, Liquidity, and Key Metrics
- Revolving facility: Senior unsecured revolving credit facility of up to $1.0425 billion.
- Term loan facility: Up to approximately $2.1447 billion, including $1.85 billion outstanding and approximately $294.7 million available as delayed-draw term loans at the Webhelp closing, subject to conditions.
- Additional capacity: Borrowing capacity may be increased by up to $500 million, subject to additional commitments and other conditions.
- Maturity: December 27, 2026; the revolving facility may be extended for two additional one-year periods with lender approval.
- Amortization: Quarterly installments equal to 1.25% of the existing principal balance plus any delayed-draw term loans, beginning December 31, 2024; remaining term-loan principal is due at maturity.
- Interest rates: SOFR-based borrowings bear SOFR plus a 1.125%–2.00% margin, with a 0.10% credit spread adjustment. Base-rate borrowings bear the applicable base rate plus a 0.125%–1.00% margin.
- Financial covenants: Consolidated leverage ratio generally may not exceed 3.75-to-1.00, or 4.25-to-1.00 during specified periods following qualifying acquisitions. Consolidated interest coverage must be at least 3.00-to-1.00.
- Guarantees: As of the amendment effective date, Concentrix subsidiaries did not guarantee the credit agreement obligations.
Material Changes Versus Prior Arrangements
- The prior bridge financing commitments totaled $5.29 billion. On April 21, 2023, the $1.85 billion Term Loan Amendment Bridge Facility and the $1.0 billion Revolving Amendment Bridge Facility were reduced to zero.
- The $2.44 billion Term Loan Acquisition Bridge Facility was reduced by approximately $294.7 million in connection with the Restated Credit Agreement.
- The new facility established permanent or longer-term senior unsecured financing capacity while retaining approximately $294.7 million of delayed-draw capacity for the Webhelp transaction.
Outlook, Risks, and Unusual Items
- Delayed-draw funding is conditional on consummation of the Webhelp combination and other customary conditions, and must be funded no later than five business days after the applicable transaction end date, subject to extensions under the transaction agreement.
- Proceeds are intended to fund part of the Webhelp acquisition, related refinancing, fees, and expenses. Revolving borrowings may be used for general corporate purposes.
- Key risks include failure to complete the transaction, inability to obtain financing on favorable terms, currency fluctuations affecting euro-denominated obligations, integration challenges, employee retention, failure to achieve expected synergies or cost savings, client or third-party disruption, litigation, cyberattacks, labor-cost increases, economic conditions, and regulatory or legal changes.
- The transaction remains subject to closing conditions, financing availability, shareholder-related disclosures and approvals, and other applicable jurisdictional requirements.
Important Facts for Investors to Verify
- Whether the Webhelp combination ultimately closed and on what terms.
- The amount and timing of any delayed-draw term loans funded at closing.
- Concentrix’s post-transaction leverage, interest coverage, liquidity, and compliance with credit covenants.
- The final purchase price, transaction-related refinancing, fees, and any additional debt or equity financing.
- Actual operating performance, synergies, integration costs, and cash flows after the transaction.
- The definitive proxy statement and subsequent SEC filings for transaction terms, shareholder interests, and closing conditions.